• Press Release

Pharmaceutical industry responds to Trade Bill amendment on medicines

Parliament has voted in favour of amendment NC17 to the Trade Bill that will make it a negotiating objective for the UK Government to seek the UK's participation in the European medicines regulatory network.

Joint statement from BIA/ABPI on EU Council meeting

At the end of June's EU Council meeting, Steve Bates, chief executive of the BIA and Mike Thompson, chief executive of the ABPI said:

BIA responds to new government investment to attract world's best in science and innovation

The BIA has to responded to the announcement from government of the inaugural UKRI Future Leaders Fellowship Scheme will receive £900 million over the next 11 years. BIA CEO Steve Bates said: “Today’s announcement will help to boost innovation in the UK and I am delighted to see that businesses will be able to use this scheme. It is vital that the UK government continues to support young entrepreneurs and business leaders to secure the innovation pipeline in the UK for the future.”

BIA welcomes new £2.5bn fund for innovative UK businesses

The BIA welcomes the creation of British Patient Capital, a £2.5 billion fund launched today by the British Business Bank. The fund will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors.

New Industrial Biotechnology Strategy launched to secure UK leadership in clean growth

Today the Industrial Biotechnology Leadership Forum (IBLF) launches the new ‘National Industrial Biotechnology Strategy to 2030’, promoted in partnership with the UK BioIndustry Association (BIA). The Strategy has been developed by the IBLF and two collaborative networks in industrial biotech, CBMNet and BIOCATNET.

BIA comment on Government response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin

The BIA has commented on the Government’s response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin.

Life Sciences sector responds to the Business, Energy and Industrial Strategy (BEIS) Committee report on the impact of Brexit on the pharmaceutical sector

A report published today [Thursday 17 May] by the BEIS Strategy Committee, calls on the Government to secure a post-Brexit deal to protect the patients in the UK and the UK's pharmaceutical industry.

BIA calls for new fund to democratise opportunities to invest in biotech

The BioIndustry Association (BIA) has called on the government to introduce a new venture capital fund structure that will give the public the opportunity to be partners in the UK’s biotech revolution. The fund should be based on the successful Enterprise Innovation Scheme (EIS) and include a new “Holding Relief”, which will reward individuals with further income tax relief if they stay invested in the long-term.

UK Bioindustry Association and the Royal College of Physicians announce new collaboration

The BioIndustry Association and the Royal College of Physicians of London (RCP) have announced a collaborative partnership, offering both memberships increased opportunities to engage on issues such as innovation, access to the NHS and regulation.  

The BIA welcomes UK ratification of the UPC Agreement

The Minister for Intellectual Property, Sam Gyimah MP, yesterday (26 April) confirmed that the UK has ratified the Unified Patent Court Agreement (UPCA).